Business · 26/12/2018
FDA Closes Comment Period for IQOS System Tobacco Product Applications
The FDA has announced the closing of a public comment period for modified risk tobacco product applications submitted by Philip Morris Products S.A. for its IQOS system products, following recent amendments to the applications.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →